| MEDLINE | Medical Literature Analysis and Retrieval System Online |
| CVD | Cardiovascular disease |
| T2DM | Type 2 diabetes mellitus |
| CKD | Chronic kidney disease |
| PAMPs | Pathogen-associated molecular patterns |
| TLRs | Toll-like receptors |
| IL-1β | Interleukin 1 beta |
| IL-6 | Interleukin 6 |
| TNF-α | Tumour necrosis factor alpha |
| SCFAs | Short-chain fatty acids |
| SANRA | Scale for the Assessment of Narrative Review Articles |
| MeSH | Medical Subject Headings |
| COVID-19 | Coronavirus Disease 2019 |
| GI | Gastrointestinal |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| NF-κB | Nuclear Factor kappa B |
| NLRP3 | NOD-like receptor pyrin domain-containing 3 |
| ROS/RNS | Reactive Oxygen Species/Reactive Nitrogen Species |
| NO | Nitric oxide |
| OR | Odds ratio |
| CI | Confidence Interval |
| MAPK | Mitogen-Activated Protein Kinase |
| LPS | Lipopolysaccharides |
| BBB | Blood–brain barrier |
| CRP | C-reactive protein |
| IL-10 | Interleukin 10 |
| CRC | Colorectal cancer |
| DNA | Deoxyribonucleic acid |
| NAFLD | Non-alcoholic fatty liver disease |
| HbA1c | Haemoglobin A1c/Glycated haemoglobin A1c |
| PPAD | Porphyromonas gingivalis peptidylarginine deiminase |
| NETosis | Neutrophil extracellular trap formation |
| RA | Rheumatoid arthritis |
| SjD | Sjögren’s disease |
| STAT3 | Signal Transducer and Activator of Transcription 3 |
| EMT | Epithelial–mesenchymal transition |
| AD | Alzheimer’s disease |
| CNS | Central nervous system |
| PD | Parkinson’s disease |
| HPA | Hypothalamic–pituitary–adrenal |
| BDNF | Brain-derived neurotrophic factor |
| NOD | Nucleotide-binding Oligomerization Domain |
| NLRs | NOD-like receptors |
| HSP | Heat shock protein |
| ICAM-1 | Intercellular Adhesion Molecule-1 |
| VCAM-1 | Vascular Cell Adhesion Molecule-1 |
| ADMA | Asymmetric dimethylarginine |
| NOS | Nitric oxide synthase |
| IE | Infective endocarditis |
| NGS | Next-generation sequencing |
| COPD | Chronic obstructive pulmonary disease |
| ACE2 | Angiotensin-converting enzyme 2 |
| IBD | Inflammatory bowel disease |
| Th17 | T helper 17 cells |
| MASLD | Metabolic dysfunction-associated steatotic liver disease |
| GDM | Gestational diabetes mellitus |
| APOs | Adverse pregnancy outcomes |
| IRS-1 | Insulin receptor substrate-1 |
| AGE | Advanced glycation end-product |
| RAGE | Receptor for advanced glycation end-products |
| TGF-β | Transforming Growth Factor beta |
| MDA | Malondialdehyde |
| EFP | European Federation of Periodontology |
| AAP | American Academy of Periodontology |
| Treg | Regulatory T cells |
| FadA | Fusobacterium adhesin A |
| MMP | Matrix Metalloproteinases |
| ACPAs | Anti-citrullinated protein antibodies |
| RANKL | Receptor Activator of Nuclear Factor κB Ligand |
| OSCC | Oral Squamous Cell Carcinoma |
| c-Myc | Cellular Myelocytomatosis oncogene |
| JAK | Janus Kinase |
| ERK | Extracellular signal-Regulated Kinase |
| RNA | Ribonucleic acid |
| Fap2 | Fusobacterium adhesin protein 2 |
| TIGIT | T cell immunoreceptor with Ig and ITIM domains |
| ITIM | Immunoreceptor Tyrosine-based Inhibitory Motif |
| PD-L1 | Programmed death ligand 1 |
| HIF-1α | Hypoxia-inducible factor-1α |
| NK | Natural killer cell |
| AI | Artificial intelligence |
| GRADE | Grading of Recommendations Assessment, Development and Evaluation |
| SSR | Summary Risk Ratio |
| DAS28 | Disease Activity Score using 28 joint counts |
| MR | Mendelian randomisation |